T. Rowe Price Associates’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$341K Buy
50,130
+7,584
+18% +$56.1K ﹤0.01% 2624
2025
Q4
$495K Buy
42,546
+3,271
+8% +$36.2K ﹤0.01% 2397
2025
Q3
$457K Buy
39,275
+7,167
+22% +$86.7K ﹤0.01% 2395
2025
Q2
$396K Buy
32,108
+5,422
+20% +$59.9K ﹤0.01% 2411
2025
Q1
$165K Buy
26,686
+3,241
+14% +$33.5K ﹤0.01% 2710
2024
Q4
$190K Buy
23,445
+5,030
+27% +$50.2K ﹤0.01% 2705
2024
Q3
$149K Buy
18,415
+2,334
+15% +$12.6K ﹤0.01% 2749
2024
Q2
$70K Buy
16,081
+1,446
+10% +$7.35K ﹤0.01% 2804
2024
Q1
$63K Buy
14,635
+2,562
+21% +$8.88K ﹤0.01% 2843
2023
Q4
$46K Hold
12,073
﹤0.01% 2816
2023
Q3
$45K Buy
+12,073
New +$48K ﹤0.01% 2789
2021
Q4
Sell
-17,527
Closed -$82K 2993
2021
Q3
$82K Hold
17,527
﹤0.01% 2870
2021
Q2
$120K Buy
17,527
+912
+5% +$7.26K ﹤0.01% 2820
2021
Q1
$166K Buy
+16,615
New +$175K ﹤0.01% 2727

Other funds holding CRMD